Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.93 |
| ▸ | EYA2 | O00167 | 1/20 | 0.93 |
| ▸ | APP | P05067 | 1/20 | 0.93 |
| ▸ | ACE | P12821 | 1/20 | 0.93 |
| ▸ | BLM | P54132 | 2/20 | 0.88 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.88 |
| ▸ | LMNA | P02545 | 1/20 | 0.88 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.88 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.88 |
| ▸ | TSHR | P16473 | 1/20 | 0.88 |
| ▸ | DRD1 | P21728 | 1/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.88 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.88 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.88 |
| ▸ | DRD3 | P35462 | 1/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.88 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL29361140 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL30163590 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL10542859 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8011334 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL3153130 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL29914630 | 1.00 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6932335 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL31314302 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL9621416 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL17416909 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11752482-B2 | Restructured hydrogel and preparing method of the same | Research & Business Foundation Sungkyunkwan University (KR) | 2023-09-12 | — | — | US | claimed |
| US-11464722-B2 | First agent for oxidation hair dye or hair decolorizing agent | HENKEL AG & CO. KGAA (DE) | 2022-10-11 | — | — | US | claimed |
| EP-4687843-A1 | FORMULATIONS AND USES THEREOF | Sartorius Albumedix Limited (GB) | 2026-02-11 | — | — | EP | disclosed |
| US-12414567-B2 | Wear resistant antimicrobial compositions and methods of use | ECOLAB USA INC. (US) | 2025-09-16 | — | — | US | disclosed |
| WO-2025099312-A1 | PEPTIDES AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF MULTIPLE SCLEROSIS | CELLERYS AG (CH) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553083-A1 | PEPTIDES AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF MULTIPLE SCLEROSIS | Cellerys AG (CH) | 2025-05-14 | — | — | EP | disclosed |
| CN-115427027-B | Agent for improving mitochondrial dysfunction | 滨特劳工公司 | 2024-12-10 | — | — | CN | disclosed |
| US-20240400655-A1 | ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF | NOVOBIND LIVESTOCK THERAPEUTICS INC. (CA) | 2024-12-05 | — | — | US | disclosed |
| CN-115397430-B | Aqueous compositions containing epinastine or salts thereof | 参天制药株式会社 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024209085-A1 | FORMULATIONS AND USES THEREOF | ALBUMEDIX LTD (GB) | 2024-10-10 | — | — | WO | disclosed |
| CN-114171769-B | Method for preparing solid oxide fuel cell stack by adopting 3D printing technology | 南方科技大学 | 2024-08-30 | — | — | CN | disclosed |
| EP-4171544-A1 | PHARMACEUTICAL FORMULATIONS OF GRISEOFULVIN FOR LONG-TERM OCULAR DELIVERY | Purdue Research Foundation (US) | 2023-05-03 | — | — | EP | disclosed |
| CN-115539008-A | High-temperature carbonate rock reservoir deep acidizing method | 四川川庆井下科技有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-3261620-B1 | METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISORDERS | UNIV ILLINOIS (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-109689862-B | Purification of recombinant EV71 virus-like particle and vaccine preparation method thereof | 北京民海生物科技有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220259293-A1 | ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF | NOVOBIND LIVESTOCK THERAPEUTICS INC. (CA) | 2022-08-18 | — | — | US | disclosed |
| WO-2022144578-A1 | METHOD AND COMPOSITION FOR MEMBRANE CLEANING | DINIAN MEHRDAD (IR) | 2022-07-07 | — | — | WO | disclosed |
| CN-111247143-B | Pyridoquinazoline derivatives useful as inhibitors of protein kinases | 昂科斯特拉公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114171769-A | Method for preparing solid oxide fuel cell stack by adopting 3D printing technology | 南方科技大学 | 2022-03-11 | — | — | CN | disclosed |
| WO-2022037153-A1 | COMPOSITE SUBSTRATE, ELECTRONIC DEVICE, AND MANUFACTURING METHOD FOR COMPOSITE SUBSTRATE | 华为技术有限公司 | 2022-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12414567-B2 | Wear resistant antimicrobial compositions and methods of use | SLC11A2, CUTA, XPA | TDP1 1782/4885EYA2 1898/4885APP 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.